ACM
TMCI icon

Aster Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Aster Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Buy
+91,740
New +$252K 0.08% 317

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Aster Capital Management's TMCI Position: Q2 2026 in Review

Aster Capital Management opened a new position in Treace Medical Concepts (TMCI) in Q2 2026: 91,740 shares worth $365K. The stake represents 0.08% of the portfolio and ranks #317 among its holdings.

117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Aster Capital Management held 91,740 shares of Treace Medical Concepts worth $365K as of Q2 2026.
  • Treace Medical Concepts was a new Aster Capital Management position in Q2 2026.
  • Treace Medical Concepts made up 0.08% of Aster Capital Management's portfolio in Q2 2026, its #317 holding.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.